Jack Elands
Chief Executive Officer at Emergence Therapeutics AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Xavier Preville | M | - |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
| Peter Neubeck | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | 5 years |
| Thierry Laugel | M | 57 |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | - |
| Aristotelis Nastos | M | 56 |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
| Irina Staatz-Granzer | M | 64 |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | 5 years |
| Franck Grimaud | M | 58 |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | - |
| Ohad Hammer | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
| Matthew Hammond | M | 35 |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
| Roy Amariglio | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick de van der Schueren | M | - |
University of Utrecht
| 7 years |
| Sjef de Kimpe | M | - |
University of Utrecht
| 10 years |
| J. F. M. Westendorp | M | 68 |
University of Utrecht
| 5 years |
| Maarten Leo Pronk | M | 69 |
University of Utrecht
| 1 years |
| Lilian Haagsman | F | - |
University of Utrecht
| 3 years |
| Joost Dröge | M | - |
University of Utrecht
| 5 years |
| Thijs Berman | M | 66 |
University of Utrecht
| 4 years |
| Joost Lagendijk | M | 67 |
University of Utrecht
| 4 years |
| Berend Scheffers | M | - |
University of Utrecht
| 4 years |
| Gerald Winkels | M | 68 |
University of Utrecht
| 1 years |
| Adrianus Johannes Antonius Kas | M | - |
University of Utrecht
| 1 years |
| Philip A. van Damme | M | 70 |
University of Utrecht
| 3 years |
| Huub den Rooijen | M | - |
University of Utrecht
| 4 years |
| Leon Hooftman | M | - |
University of Utrecht
| 3 years |
| Maarten Antonius Johannes van den Belt | M | - |
University of Utrecht
| 4 years |
| Ronald E. E. Scherpenhuijsen Rom | M | 65 |
University of Utrecht
| 4 years |
| Gerardus Wilhelmus van Odijk | M | 67 |
University of Utrecht
| 3 years |
| Heiko Balder | M | - |
University of Utrecht
| 1 years |
| Bharat Tewarie | M | - |
University of Utrecht
| 4 years |
| Jeff Gielen | M | 72 |
University of Utrecht
| 3 years |
| Peter van Stiphout | M | - |
University of Utrecht
| 3 years |
| Adrianus van Wijk | M | 68 |
University of Utrecht
| 4 years |
| Kees van der Leun | M | - |
University of Utrecht
| 4 years |
| Marco Baptist Arie Keim | M | 62 |
University of Utrecht
| 3 years |
| Aalt Dijkhuizen | M | 70 |
University of Utrecht
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 25 | 73.53% |
| Germany | 7 | 20.59% |
| France | 2 | 5.88% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jack Elands
- Personal Network
